MannKind Corp
MNKD
#5686
Rank
HK$10.52 B
Marketcap
HK$34.08
Share price
2.48%
Change (1 day)
16.07%
Change (1 year)

Market capitalization of MannKind Corp (MNKD)

Market cap: HK$10.52 Billion

As of June 2026 MannKind Corp has a market cap of HK$10.52 Billion. This makes MannKind Corp the world's 5686th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MannKind Corp from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$10.52 B-23.9%
2025HK$13.83 B-5.26%
2024HK$14.60 B90.53%
2023HK$7.66 B-29.28%
2022HK$10.83 B26.58%
2021HK$8.56 B49.72%
2020HK$5.71 B168.75%
2019HK$2.12 B37.05%
2018HK$1.55 B-27.95%
2017HK$2.15 B-8.77%
2016HK$2.36 B-50.97%
2015HK$4.81 B-70.67%
2014HK$16.42 B10.27%
2013HK$14.89 B190.83%
2012HK$5.12 B100.83%
2011HK$2.55 B-68.18%
2010HK$8.01 B4.41%
2009HK$7.67 B183.94%
2008HK$2.70 B-57.03%
2007HK$6.29 B-33.12%
2006HK$9.40 B232.71%
2005HK$2.82 B-28.67%
2004HK$3.96 B

End of Day market cap according to different sources

On Jun 29th, 2026 the market cap of MannKind Corp was reported to be:

HK$10.27 Billion
by Nasdaq info icon info icon
HK$10.27 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
HK$1.079 T 10,151.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
HK$1.669 T 15,760.51%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
HK$8.465 T 80,312.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$2.496 T 23,612.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
HK$72.87 B 592.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
HK$18.50 B 75.80%๐Ÿ‡บ๐Ÿ‡ธ USA